Treatment Options for Essential Tremor: Understanding the Differences from Parkinson’s Disease

Essential tremor is a neurological disorder that causes involuntary shaking, typically in the hands, head, and voice. It is important to differentiate between essential tremor and Parkinson’s disease (PD) as the treatment options differ. Propranolol is considered the first-line treatment for essential tremor, while levodopa is used for PD.

To distinguish between the two conditions, it is important to note that essential tremor worsens with movement and is often symmetrical, while PD tremors occur mostly at rest and are asymmetrical. Additionally, essential tremor often has a family history component.

Other medications, such as diazepam, fluoxetine, and gabapentin, are not typically used for essential tremor. Diazepam is used for acute muscle spasms and anxiety, fluoxetine is used for depression and other mental health conditions, and gabapentin is used for seizure disorders and neuropathic pain.

In summary, understanding the differences between essential tremor and PD is crucial in determining the appropriate treatment options. Propranolol is the preferred medication for essential tremor, while levodopa is used for PD.

Understanding Alcohol Dependence: Symptoms and Screening Tools

Alcohol dependence is a serious condition characterized by a strong compulsion to drink, withdrawal symptoms, tolerance, and loss of control over alcohol use. This vignette illustrates a classic scenario of alcohol dependence, with features of tolerance, withdrawals, neglect of other pleasures, and low mood associated with heavy chronic alcohol consumption. While depression can be a symptom of alcohol dependence, it is not the primary diagnosis.

The term alcohol abuse is being replaced by alcohol-use disorder or harmful drinking to describe patterns of alcohol use that cause physical or mental health damage. In this vignette, the woman likely has harmful use of alcohol, but the overall picture points to a diagnosis of alcohol dependence.

Withdrawal symptoms are a common feature of alcohol dependence, and the woman in this vignette would likely experience them if she suddenly stopped drinking. Social withdrawal is also an indicator of alcohol dependence, but it does not explain the entire pattern of symptoms and behavior presented.

A useful screening test for alcohol-use disorders is the CAGE questionnaire, which asks about cutting down, annoyance from others, guilt, and needing a drink first thing in the morning. Answering yes to two or more questions may indicate the presence of an alcohol-use disorder. Other screening tools include the FAST and AUDIT tests, which can be administered quickly in busy medical settings.

Overall, understanding the symptoms and screening tools for alcohol dependence is crucial for early detection and intervention.

According to NICE (2017) guidelines, patients with asthma should be prescribed a SABA as the first step of treatment. However, if a patient experiences symptoms three or more times per week or night waking, they should also be prescribed a low-dose ICS inhaler as the second step of treatment. This is also necessary for patients who have had an acute exacerbation requiring oral corticosteroids in the past two years. In this case, the patient’s symptoms are not well-controlled with a SABA alone, and she experiences frequent symptoms and night waking. Therefore, she requires a low-dose ICS inhaler, and the only option available is budesonide.

Adding a salmeterol inhaler is not appropriate at this stage, as LABAs are only used as the fourth step of treatment if a patient is not controlled with a SABA, low-dose ICS, and a trial of LTRAs. Similarly, adding montelukast and a beclomethasone inhaler is not appropriate, as LTRAs are only added if a patient is still not controlled on a low-dose ICS and a SABA. However, it may be appropriate to trial beclomethasone without montelukast.

Continuing with the current salbutamol-only treatment is not appropriate, as the patient’s asthma is poorly controlled, which increases the risk of morbidity and mortality. Regular salbutamol has no role in the management of asthma, as it does not improve outcomes and may even worsen them by downregulating beta receptors that are important for bronchodilation.

The management of asthma in adults has been updated by NICE in 2017, following the 2016 BTS guidelines. One of the significant changes is in ‘step 3’, where patients on a SABA + ICS whose asthma is not well controlled should be offered a leukotriene receptor antagonist instead of a LABA. NICE does not follow the stepwise approach of the previous BTS guidelines, but to make the guidelines easier to follow, we have added our own steps. The steps range from newly-diagnosed asthma to SABA +/- LTRA + one of the following options, including increasing ICS to high-dose, a trial of an additional drug, or seeking advice from a healthcare professional with expertise in asthma. Maintenance and reliever therapy (MART) is a form of combined ICS and LABA treatment that is only available for ICS and LABA combinations in which the LABA has a fast-acting component. It should be noted that NICE does not recommend changing treatment in patients who have well-controlled asthma simply to adhere to the latest guidance. The definitions of what constitutes a low, moderate, or high-dose ICS have also changed, with <= 400 micrograms budesonide or equivalent being a low dose, 400 micrograms - 800 micrograms budesonide or equivalent being a moderate dose, and > 800 micrograms budesonide or equivalent being a high dose for adults.

Topical corticosteroids can lead to patchy depigmentation in patients with darker skin, which is a potential adverse effect. These medications are commonly used to reduce inflammation in skin conditions like psoriasis and eczema. However, if used for an extended period or in high doses, they can cause local side effects such as skin thinning, excessive hair growth, and depigmentation. Therefore, the correct answer is depigmentation. Dry skin is not a typical side effect of topical steroid use, but it can occur with other topical preparations like benzoyl peroxide and topical retinoids. While systemic side effects like weight gain, hyperglycemia, hypertension, and mood changes are possible with corticosteroids, they are rare with topical use. Hyperglycemia is therefore an incorrect answer. Reduced hair growth at the application site is also incorrect, as corticosteroids can actually increase hair growth and may be used to treat alopecia.

Topical Steroids for Eczema Treatment

Eczema is a common skin condition that causes red, itchy, and inflamed skin. Topical steroids are often used to treat eczema, but it is important to use the weakest steroid cream that effectively controls the patient’s symptoms.

To determine the appropriate amount of topical steroid to use, the finger tip rule can be used. One finger tip unit (FTU) is equivalent to 0.5 g and is sufficient to treat an area of skin about twice the size of an adult hand.
The British National Formulary (BNF) recommends specific quantities of topical steroids to be prescribed for a single daily application for two weeks. These recommendations vary depending on the area of the body being treated. It is important to follow these guidelines to ensure safe and effective use of topical steroids for eczema treatment.

Acute epiglottitis is a medical emergency that requires prompt management to prevent airway obstruction. It is caused by inflammation of the epiglottis and is most common in children. Symptoms include fever, sore throat, difficulty swallowing, and respiratory distress. The most severe cases can lead to complete airway obstruction, which can be fatal.

The most important initial step in management is to call for an anaesthetist to intubate the child. Attempting to administer treatment via a facemask or examining the child’s throat can cause distress and increase the risk of complete airway obstruction. The anaesthetist should be present during any examination or treatment to ensure the safety of the child.

In summary, acute epiglottitis is a medical emergency that requires prompt management to prevent airway obstruction. Calling for an anaesthetist to intubate the child is the most important initial step in management. Any examination or treatment should be done with the anaesthetist present to ensure the safety of the child.

Lumbar spinal canal stenosis is often indicated by a history of progressive painful neurological deficit that improves when resting or leaning forward. This condition causes nerve root ischaemia due to inadequate microvascular blood flow to the spinal nerve roots, resulting in bilateral neuropathic pain and progressive deficit affecting the dermatomes and myotomes below the affected level. Leaning forward widens the canal, providing relief, while resting reduces the oxygen requirement of the nerve roots, allowing the ischaemia to slowly resolve. Neurological examination of the legs usually shows no abnormal findings as the symptoms are only brought on by consistent use of the nerve roots.

Osteoarthritis, on the other hand, is a degenerative arthropathy that typically affects large weight-bearing joints in the lower limbs, causing pain that rarely improves with rest and is not associated with a neurological deficit. It is usually unilateral and does not cause symmetrical symptoms.

Peripheral neuropathy can produce similar symptoms to spinal stenosis, but the pathology is not related to nerve use, and a deficit (usually sensory) would be detected on examination. The absence of such findings indicates that peripheral neuropathy is not the cause.

Peripheral vascular disease is the most likely differential for patients with spinal stenosis and symptoms of progressive leg pain that is relieved by rest. However, evidence of vascular insufficiency, such as absent distal pulses, ulceration or skin changes, would be present on examination if the condition were severe enough to cause symptoms after relatively short distances of walking. Additionally, leaning forward does not improve symptoms in peripheral vascular disease, only rest does.

Lumbar spinal stenosis is a condition where the central canal in the lower back is narrowed due to degenerative changes, such as a tumor or disk prolapse. Patients may experience back pain, neuropathic pain, and symptoms similar to claudication. However, one distinguishing factor is that the pain is positional, with sitting being more comfortable than standing, and walking uphill being easier than downhill. Degenerative disease is the most common cause, starting with changes in the intervertebral disk that lead to disk bulging and collapse. This puts stress on the facet joints, causing cartilage degeneration, hypertrophy, and osteophyte formation, which narrows the spinal canal and compresses the nerve roots of the cauda equina. MRI scanning is the best way to diagnose lumbar spinal stenosis, and treatment may involve a laminectomy.

Overall, lumbar spinal stenosis is a condition that affects the lower back and can cause a range of symptoms, including pain and discomfort. It is often caused by degenerative changes in the intervertebral disk, which can lead to narrowing of the spinal canal and compression of the nerve roots. Diagnosis is typically done through MRI scanning, and treatment may involve a laminectomy. It is important to note that the pain associated with lumbar spinal stenosis is positional, with sitting being more comfortable than standing, and walking uphill being easier than downhill.

Reassurance and advice can be provided to manage nocturnal enuresis in children under the age of 5 years.

Nocturnal enuresis, or bedwetting, is when a child involuntarily urinates during the night. Most children achieve continence by the age of 3 or 4, so enuresis is defined as the involuntary discharge of urine in a child aged 5 or older without any underlying medical conditions. Enuresis can be primary, meaning the child has never achieved continence, or secondary, meaning the child has been dry for at least 6 months before.

When managing bedwetting, it’s important to look for any underlying causes or triggers, such as constipation, diabetes mellitus, or recent onset UTIs. General advice includes monitoring fluid intake and encouraging regular toileting patterns, such as emptying the bladder before sleep. Reward systems, like star charts, can also be helpful, but should be given for agreed behavior rather than dry nights.

The first-line treatment for bedwetting is an enuresis alarm, which has a high success rate. These alarms have sensor pads that detect wetness and wake the child up to use the toilet. If short-term control is needed, such as for sleepovers, or if the alarm is ineffective or not acceptable to the family, desmopressin may be prescribed. Overall, managing bedwetting involves identifying any underlying causes and implementing strategies to promote continence.

Understanding Nasal Polyps

Nasal polyps are a relatively uncommon condition affecting around 1% of adults in the UK. They are more commonly seen in men and are not typically found in children or the elderly. There are several associations with nasal polyps, including asthma (particularly late-onset asthma), aspirin sensitivity, infective sinusitis, cystic fibrosis, Kartagener’s syndrome, and Churg-Strauss syndrome. When asthma, aspirin sensitivity, and nasal polyposis occur together, it is known as Samter’s triad.

The symptoms of nasal polyps include nasal obstruction, rhinorrhoea, sneezing, and a poor sense of taste and smell. It is important to note that any unusual symptoms, such as unilateral symptoms or bleeding, require further investigation. If nasal polyps are suspected, patients should be referred to an ear, nose, and throat (ENT) specialist for a full examination.

The management of nasal polyps typically involves the use of topical corticosteroids, which can shrink polyp size in around 80% of patients. Overall, understanding nasal polyps and their associations can help with early detection and appropriate management.

Tear-drop scaly papules suddenly appearing on the trunk and limbs may indicate guttate psoriasis.

Guttate psoriasis is a type of psoriasis that is more commonly seen in children and adolescents. It is often triggered by a streptococcal infection that occurred 2-4 weeks prior to the appearance of the lesions. The name guttate comes from the Latin word for drop, as the lesions appear as small, tear-shaped papules on the trunk and limbs. These papules are pink and scaly, and the onset of the condition is usually acute, occurring over a few days.

In most cases, guttate psoriasis will resolve on its own within 2-3 months. There is no clear evidence to support the use of antibiotics to treat the underlying streptococcal infection. Treatment options for guttate psoriasis include topical agents commonly used for psoriasis and UVB phototherapy. In cases where the condition recurs, a tonsillectomy may be necessary.

It is important to differentiate guttate psoriasis from pityriasis rosea, another skin condition that can present with similar symptoms. Guttate psoriasis is often preceded by a streptococcal sore throat, while pityriasis rosea may be preceded by a respiratory tract infection. The appearance of guttate psoriasis is characterized by tear-shaped papules on the trunk and limbs, while pityriasis rosea presents with a herald patch followed by multiple oval lesions with a fine scale. While guttate psoriasis resolves within a few months, pityriasis rosea typically resolves after around 6 weeks.

Prescribing pyridoxine can help lower the risk of peripheral neuropathy associated with isoniazid.

Side-Effects and Mechanism of Action of Tuberculosis Drugs

Rifampicin is a drug that inhibits bacterial DNA dependent RNA polymerase, which prevents the transcription of DNA into mRNA. However, it is a potent liver enzyme inducer and can cause hepatitis, orange secretions, and flu-like symptoms.

Isoniazid, on the other hand, inhibits mycolic acid synthesis. It can cause peripheral neuropathy, which can be prevented with pyridoxine (Vitamin B6). It can also cause hepatitis and agranulocytosis. Additionally, it is a liver enzyme inhibitor.

Pyrazinamide is converted by pyrazinamidase into pyrazinoic acid, which in turn inhibits fatty acid synthase (FAS) I. However, it can cause hyperuricaemia, leading to gout, as well as arthralgia, myalgia, and hepatitis.

Lastly, Ethambutol inhibits the enzyme arabinosyl transferase, which polymerizes arabinose into arabinan. It can cause optic neuritis, so it is important to check visual acuity before and during treatment. Additionally, the dose needs adjusting in patients with renal impairment.

In summary, these tuberculosis drugs have different mechanisms of action and can cause various side-effects. It is important to monitor patients closely and adjust treatment accordingly to ensure the best possible outcomes.